MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 18 April 2007-PuriCore (LSE: PURI), the life sciences company focused on the development and commercialisation of its novel, safe antimicrobial technology, today announces that the following Directors have purchased shares in the Company, as set out below:
